HBIO
Price
$8.03
Change
-$0.12 (-1.47%)
Updated
Sep 11 closing price
Capitalization
36.51M
59 days until earnings call
Intraday BUY SELL Signals
TELA
Price
$0.97
Change
+$0.06 (+6.59%)
Updated
Sep 11 closing price
Capitalization
42.65M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HBIO vs TELA

HBIO vs TELA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HBIO vs. TELA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and TELA is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TELA($42.7M) has a higher market cap than HBIO($36.5M). HBIO YTD gains are higher at: 20.066 vs. TELA (-17.797). HBIO has higher annual earnings (EBITDA): 1.36M vs. TELA (-32.94M). TELA has more cash in the bank: 30.4M vs. HBIO (6.5M). HBIO has less debt than TELA: HBIO (44.2M) vs TELA (56.6M). HBIO has higher revenues than TELA: HBIO (87.8M) vs TELA (79.9M).
HBIOTELAHBIO / TELA
Capitalization36.5M42.7M85%
EBITDA1.36M-32.94M-4%
Gain YTD20.066-17.797-113%
P/E RatioN/AN/A-
Revenue87.8M79.9M110%
Total Cash6.5M30.4M21%
Total Debt44.2M56.6M78%
FUNDAMENTALS RATINGS
HBIO vs TELA: Fundamental Ratings
HBIO
TELA
OUTLOOK RATING
1..100
4443
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
3546
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TELA's Valuation (40) in the null industry is somewhat better than the same rating for HBIO (100) in the Biotechnology industry. This means that TELA’s stock grew somewhat faster than HBIO’s over the last 12 months.

TELA's Profit vs Risk Rating (100) in the null industry is in the same range as HBIO (100) in the Biotechnology industry. This means that TELA’s stock grew similarly to HBIO’s over the last 12 months.

HBIO's SMR Rating (98) in the Biotechnology industry is in the same range as TELA (100) in the null industry. This means that HBIO’s stock grew similarly to TELA’s over the last 12 months.

HBIO's Price Growth Rating (35) in the Biotechnology industry is in the same range as TELA (46) in the null industry. This means that HBIO’s stock grew similarly to TELA’s over the last 12 months.

HBIO's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for TELA (100) in the null industry. This means that HBIO’s stock grew significantly faster than TELA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HBIOTELA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
71%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (HBIO: $8.03 vs. TELA: $0.97)
Brand notoriety: HBIO and TELA are both not notable
HBIO represents the Pharmaceuticals: Other, while TELA is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 31% vs. TELA: 114%
Market capitalization -- HBIO: $36.51M vs. TELA: $42.65M
HBIO [@Pharmaceuticals: Other] is valued at $36.51M. TELA’s [@Medical/Nursing Services] market capitalization is $42.65M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green while TELA’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • TELA’s FA Score: 0 green, 5 red.
According to our system of comparison, both HBIO and TELA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 3 TA indicator(s) are bullish while TELA’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 3 bullish, 4 bearish.
  • TELA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TELA is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а +0.12% price change this week, while TELA (@Medical/Nursing Services) price change was +18.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 10, 2026.

TELA is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
HBIO
Daily Signal:
Gain/Loss:
TELA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSBPX33.83N/A
N/A
Principal SmallCap R5
RGCIX10.21N/A
N/A
Russell Inv Global Infrastructure C
HRSIX106.63N/A
N/A
Hood River Small-Cap Growth Retirement
FWOZX21.37N/A
N/A
Fidelity Advisor Women's Leadership Z
CNPIX76.88N/A
N/A
Consumer Staples UltraSector ProFund Inv

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-1.47%
IRMD - HBIO
46%
Loosely correlated
+0.43%
A - HBIO
37%
Loosely correlated
+2.66%
RVTY - HBIO
36%
Loosely correlated
+2.79%
MTD - HBIO
35%
Loosely correlated
+1.01%
NEOG - HBIO
34%
Loosely correlated
+0.08%
More

TELA and

Correlation & Price change

A.I.dvisor tells us that TELA and BAX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and BAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELA
1D Price
Change %
TELA100%
+7.17%
BAX - TELA
28%
Poorly correlated
-1.57%
AMIX - TELA
28%
Poorly correlated
-0.34%
HBIO - TELA
27%
Poorly correlated
-1.47%
TFX - TELA
27%
Poorly correlated
-0.77%
AZTA - TELA
26%
Poorly correlated
+2.22%
More